Production (Stage)
Conduit Pharmaceuticals Inc.
CDT
$2.35
$0.020.86%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.70M | 4.65M | 2.32M | 3.12M | 2.83M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.01M | 4.78M | 5.41M | 3.14M | 2.96M |
| Operating Income | -4.01M | -4.78M | -5.41M | -3.14M | -2.96M |
| Income Before Tax | -5.15M | -2.41M | -6.46M | -5.38M | -3.55M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.15M | -2.41M | -6.46M | -5.38M | -3.55M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.15M | -2.41M | -6.46M | -5.38M | -3.55M |
| EBIT | -4.01M | -4.78M | -5.41M | -3.14M | -2.96M |
| EBITDA | -3.82M | -4.33M | -5.41M | -- | -- |
| EPS Basic | -19.86 | -32.25 | -111.20 | -109.34 | -72.17 |
| Normalized Basic EPS | -13.97 | -28.22 | -60.97 | -68.33 | -45.10 |
| EPS Diluted | -19.86 | -32.25 | -111.20 | -109.34 | -72.17 |
| Normalized Diluted EPS | -13.97 | -28.22 | -60.97 | -68.33 | -45.10 |
| Average Basic Shares Outstanding | 259.10K | 74.60K | 58.10K | 49.20K | 49.20K |
| Average Diluted Shares Outstanding | 259.10K | 74.60K | 58.10K | 49.20K | 49.20K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |